CHAPTER 10
REFERENCES
FIBROSIS
1. Arcidi JM Jr, Moore GW, Hutchins GM: Hepatic morphology in cardiac dysfunction. A clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 104: 159-166, 1981.
2. Bacon BR, Britton RS: The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 11: 127-137, 1990.
3. Baptista A, Bianchi L, DeGroote J, et al: The diagnostic significance of periportal hepatic necrosis and inflammation. Histopathology 12: 569-579, 1988.
4. Barbatis C, Grases P, Shepherd HA, et al: Histological features of sclerosing cholangitis in patients with ulcerative colitis. J Clin Pathol 38: 778-783, 1985.
5. Bernstein J, Stickler GB, Neel IV: Congenital hepatic fibrosis: Evolving morphology. APMIS (suppl 4): 17-26, 1988.
6. Bianchi L, DeGroote J, Desmet VJ, et al: Morphological criteria in viral hepatitis. Review by an international group. Lancet 1: 333-336, 1971.
7. Bioulac-Sage P, Quinton A, Saric J, et al: Chance discovery of hepatic fibrosis in patient with asymptomatic hypervitaminosis A. Arch Pathol Lab Med 112: 505-509, 1988.
8. Bissell DM: Cell-matrix interaction and hepatic fibrosis. Prog Liver Dis 9: 143-155, 1990.
9. Bissell DM, Friedman SL, Maher JJ, Roll FJ: Connective tissue biology and hepatic fibrosis: Report of a conference. Hepatology 11: 488-498, 1990.
10. Bosma A, Meuwissen SGM, Stricker BHCh, Brouwer A: Massive pericellular collagen deposition in the liver of a young female with severe Crohns's disease. Histopathology 14: 81-90, 1989.
11. Bucher N, Robinson G, Farmer S: Effects of extracellular matrix on hepatocyte growth and gene expression: Implications for hepatic regeneration and the repair of liver injury. Semin Liver Dis 10: 11-19, 1990.
12. Castilla A, Prieto J, Fausto N: Transforming growth factors
13. Caulet S, Fabre M, Schoevaert D, et al: Quantitative study of centrolobular hepatic fibrosis in alcoholic disease before cirrhosis. Virchows Arch [A] 416: 11-17, 1989.
14. Clement B, Grimaud J-A, Campion J-P, et al: Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology 6: 225-234, 1986.
15. Desmet VJ: What is congenital hepatic fibrosis? Histopathology 20: 465-477, 1992.
16. Fallon HJ: Alcohol and the terminal hepatic venule: Early lesion or late residual? Gastroenterology 83: 930-932, 1982.
17. Gerber MA, Popper H: Relation between central canals and portal tracts in alcoholic hepatitis. A contribution to the pathogenesis of cirrhosis in alcoholics. Hum Pathol 3: 199-207, 1972.
18. Gerber MA, Thung SN: Histology of the liver. Am J Surg Pathol 11: 709-722, 1987.
19. Geubel AP, De Galocsy C, Alves N, et al: Liver damage caused by therapeutic vitamin A administration: Estimate of dose-related toxicity in 41 cases. Gastroenterology 100: 1701-1709, 1991.
20. Horn T, Junge J, Christoffersen P: Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J Hepatol 3: 333-340, 1986.
21. Keen ME, Engstrand DA, Hafez G-R: Hepatic lipogranulomatosis simulating veno-occlusive disease of the liver. Arch Pathol Lab Med 109: 70-72, 1985.
22. Korn RJ, Kellow WF, Heller P, et al: Hepatic involvement in extrapulmonary tuberculosis. Histologic and functional characteristics. Am J Med 27: 60-71, 1959.
23. Lafon ME, Bioulac-Sage P, Grimaud JA, et al: Perisinusoidal fibrosis in the liver of patients with thrombocytopenic purpura. Virchows Arch [A] 411: 553-559, 1987.
24. Lefkowitch JH, Mendez L: Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2: 313-327, 1986.
25. Ludwig J: New concepts in biliary cirrhosis. Sem Liver Dis 7: 293-301, 1987.
26. Ludwig J, Czaja AJ, Dickson ER, et al: Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver 4: 105-118, 1984.
27. Ludwig J, Gross JR Jr, Perkins JD, Moore SB: Persistent centrilobular necrosis in hepatic allografts. Hum Pathol 21: 656-661, 1990.
28. Maher JJ: Hepatic fibrosis caused by alcohol. Semin Liver Dis 10: 66-74, 1990.
29. Minuk GY, Kelly JK, Hwang W-S: Vitamin A hepatotoxicity in multiple family members. Hepatology 8: 272-275, 1988.
30. Morgan MY, Sherlock S, Scheuer PJ: Portal fibrosis in the livers of alcoholic patients. Gut 19: 1015-1021, 1978.
31. Nagy P, Schaff Z, Lapis K: Immunohistochemical detection of transforming growth factor-
β1 in fibrotic liver diseases. Hepatology 14: 269-273, 1991.32. Nakanuma Y, Ohta G, Kobayashi K, Kato Y: Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules. Am J Gastroenterol 7: 405-413, 1982.
33. Nasrallah SM, Nassar VH, Galambos JT: Importance of terminal hepatic venule thickening. Arch Pathol Lab Med 104: 84-86, 1980.
34. Nevens F, Fevery J, Van Steenbergen W, et al: Arsenic and noncirrhotic portal hypertension: A report of eight cases. J Hepatol 11: 80-95, 1990.
35. Okanoue T, Burbige EJ, French SW: The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med 107: 459-463, 1982.
36. Oliva A, Duarte B, Jonasson O, Nadimpalli V: The nodular form of local hepatic tuberculosis. A review. J Clin Gastroenterol 12: 166-173, 1990.
37. Oppenheimer EH, Dahms BB: Congenital syphilis in the fetus and neonate. Perspect Pediatr Pathol 6: 115-138, 1981.
38. Parfrey NA, Hutchins GM: Hepatic fibrosis in the mucopolysaccharidoses. Am J Med 81: 825-829, 1986.
39. Popper H: General pathology of the liver: Light microscopic aspects serving diagnosis and interpretation. Semin Liver Dis 6: 175-184, 1986.
40. Qizilbash A, Kontozoglou T, Sianos J, Scully K: Hepar lobatum associated with chemotherapy and metastatic breast cancer. Arch Pathol Lab Med 111: 58-61, 1987.
41. Rappaport AM, MacPhee PJ, Fisher MM, Phillips MJ: The scarring of the liver acini (cirrhosis). Tridimensional and microcirculatory considerations. Virchows Arch [A] 402: 107-137, 1983.
42. Reid LM, Fiorino AS, Sigal SH, et al: Extracellular matrix gradients in the space of Disse: Relevance to liver biology. Hepatology 15: 1198-1203, 1992.
43. Rojkind M, Greenwel P: The liver as a bioecological system. In: Arias IM, Jakoby WB, Popper H, et al (eds): The Liver: Biology and Pathobiology, 2nd ed. New York, Raven Press, 1988. pp. 1269-1285.
44. Rollins BJ: Hepatic veno-occlusive disease. Am J Med 81: 297-306, 1986.
45. Sarin SK: Non-cirrhotic portal fibrosis. Gut 30: 406-415, 1989.
46. Schuppan D: Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins. Semin Liv Dis 10: 1-10, 1990.
47. Tolman KG, Clegg DO, Lee RG, Ward JR: Methotrexate and the liver. J Rheumatol 12 (suppl 12): 29-34, 1985.
48. Valla D, Pessegueiro-Miranda H, Degott C, et al: Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med 63: 531-544, 1987.
49. Wanless IR, Bernier V, Seger M: Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study. Am J Pathol 106: 63-70, 1982.
50. Worner TM, Lieber CS: Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254: 627-630, 1985.
CIRRHOSIS
51. Almdal TP, Sørensen TIA, the Danish Association for the Study of the Liver: Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: Analysis of hospitalization registry data. Hepatology 13: 650-655, 1991.
52. Anthony PP, Ishak KG, Nayak NC, et al: The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 31: 395-414, 1978.
53. Baggenstoss AH: Morphological features: Their usefulness in the diagnosis, prognosis, and management of cirrhosis. Clin Gastroenterol 4: 227-246, 1975.
54. Barnett JL, Appelman HD, Moseley RH: A familial form of incomplete septal cirrhosis. Gastroenterology 102: 674-678, 1992.
55. Borzio M, Bruno S, Roncalli M, et al: Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report. Br Med J 302: 1312, 1991.
56. Callea F, Brisigotti M, Fabbretti G, et al: Cirrhosis of the liver. A regenerative process. Dig Dis Sci 36: 1287-1293, 1991.
57. Caporaso N, Romano M, Marmo R, et al: Hepatitis C infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 12: 367-371, 1991.
58. Chojkier M, Brenner DA: Therapeutic stragegies for hepatic fibrosis. Hepatology 8: 176-182, 1988.
59. Conn HO, Atterbury CE: Cirrhosis. In: Schiff L, Schiff ER (eds): Diseases of the Liver, 6th ed. Philadelphia, JB Lippincott, 1987. pp. 725-864.
60. D'Amico G, Morabito A, Pagliaro L, et al: Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 31: 468-475, 1986.
61. Eckhauser FE, Appelman HD, O'Leary TJ, et al: Hepatic pathology as a determinant of prognosis after portal decompression. Am J Surg 139: 105-112, 1980.
62. Fauerholdt L, Schlichting P, Christensen E, et al: Conversion of micronodular cirrhosis into macronodular cirrhosis. Hepatology 3: 928-931, 1983.
63. Fausto N, Mead JE: Regulation of liver growth: Protooncogenes and transforming growth factors. Lab Invest 60: 4-13, 1989.
64. Gall EA: Posthepatitic, postnecrotic, and nutritional cirrhosis. A pathologic analysis. Am J Pathol 37: 241-258, 1960.
65. Garagliano CF, Lilienfeld AM, Mendeloff AI: Incidence rates of liver cirrhosis and related diseases in Baltimore and selected areas of the United States. J Chron Dis 32: 543-554, 1979.
66. Gluud C, Christoffersen P, Eriksen J, et al: Influence of ethanol on development of hyperplastic nodules in alcoholic men with micronodular cirrhosis. Gastroenterology 93: 256-260, 1987.
67. Groszmann RJ, Atterbury CE: The pathophysiology of portal hypertension: A basis for classification. Semin Liver Dis 2: 177-186, 1982.
68. Hay JE, Czaja AJ, Rakela J, Ludwig J: The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 7: 49-54, 1987.
69. Horney JT, Galambos JT: The liver during and after fulminant hepatitis. Gastroenterology 73: 639-645, 1977.
70. Infante-Rivard C, Esnaola S, Villeneuve JP: Clinical and stastical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 7: 660-664, 1987.
71. Karvountzis GG, Redeker AG, Peters RL: Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterology 67: 870-877, 1974.
72. Labrecque DR: Hepatocyte growth factor -- How do I know thee? Let me count the ways. Gastroenterology 103: 1686-1691, 1992.
73. Lewis JH, Mullick F, Ishak KG, et al: Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol 21: 59-67, 1990.
74. Lombard CM, Strauchen JA: Postshunt hemochromatosis with cardiomyopathy. Hum Pathol 12: 1149-1151, 1981.
75. Maddrey WC, Van Thiel DH: Liver transplantation: An overview. Hepatology 8: 948-959, 1988.
76. Marbet UA, Bianchi L, Meury U, Stalder GA: Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 4: 364-372, 1987.
77. Michalopoulos GK, Zarnegar R: Hepatocyte growth factor. Hepatology 15: 149-155, 1992.
78. Nakanuma Y, Ohta G, Doishita K: Quantitation and serial section observations of focal venocclusive lesions of hepatic veins in liver cirrhosis. Virchows Arch [A] 405: 429-438, 1985.
79. Nyfors A, Poulsen H: Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis. Am J Surg Pathol 1: 235-243, 1977.
80. Okuda K: Hepatocellular carcinoma: Recent progress. Hepatology 15: 948-963, 1992.
81. Orrego H, Blake JE, Blendis LM, Medline A: Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 92: 208-214, 1987.
82. Orrego H, Israel Y, Blendis LM: Alcoholic liver disease: Information in search of knowledge? Hepatology 1: 267-283, 1981.
83. Popper H: Pathologic aspects of cirrhosis. A review. Am J Pathol 87: 228-258, 1977.
84. Rubin E, Popper H: The evolution of human cirrhosis deduced from observations in experimental animals. Medicine 46: 163-183, 1967.
85. Saunders JB, Walters JFR, Davies P, Paton A: A 20-year prospective study of cirrhosis. Br Med J 282: 263-266, 1981.
86. Scheuer PJ: Liver biopsy in the diagnosis of cirrhosis. Gut 11: 275-278, 1970.
87. Scheuer PJ, Maggi G: Hepatic fibrosis and collapse: histological distinction by orcein staining. Histopathology 4: 487-490, 1980.
88. Schlichting P, Christensen E, Andersen PK, et al: Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 3: 889-895, 1983.
89. Schlichting P, Fauerholdt L, Christensen E, et al: Clinical relevance of restrictive morphological criteria for the diagnosis of cirrhosis in liver biopsies. Liver 1: 56-81, 1981.
90. Sciot R, Staessen D, Van Damme B, et al: Incomplete septal cirrhosis: histological aspects. Histopathology 13: 593-603, 1988.
91. Sumithran E, Looi LM: Copper-binding protein in liver cells. Hum Pathol 16: 677-682, 1985.
92. Takahashi T: Three-dimensional morphology of the liver in cirrhosis. Virchows Arch [A] 377: 97-110, 1978.
93. Thung SN, Gerber MA: The formation of elastic fibers in livers with massive hepatic necrosis. Arch Pathol Lab Med 106: 468-469, 1982.
94. Tinè F, Pagliaro L: Cirrhosis and its recognition in asymptomatic subjects with aminotranferase elevation. Hepatology 11: 516-518, 1990.
95. Whitington PF, Balistreri WF: Liver transplantation in pediatrics: Indications, contraindications, and pretransplant management. J Pediatr 118: 169-177, 1991.
96. Yeong ML, Nicholson GI, Lee SP: Regression of biliary cirrhosis following choledochal cyst drainage. Gastroenterology 82: 332-335, 1982.
NODULAR REGENERATIVE HYPERPLASIA
97. Colina F, Alberti N, Solis JA, Martinez-Tello FJ: Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 9: 253-265, 1989.
98. Flejou J-F, Barge J, Menu Y, et al: Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 89: 1132-1138, 1985.
99. LeBail B, Jouhanole H, Deugnier Y, et al: Liver adenomatosis with granulomas in two patients on long-term oral contraceptives. Am J Surg Pathol 16: 982-987, 1992.
100. Morales JM, Prieto C, Colina F, et al: Nodular regenerative hyperplasia of the liver in renal transplantation. Transplant Proc 19: 3694-3696, 1987.
101. Moran CA, Mullick FG, Ishak KG: Nodular regenerative hyperplasia of the liver in children. Am J Surg Pathol 15: 449-454, 1991.
102. Nakanuma Y: Nodular regenerative hyperplasia of the liver: Retrospective survey in autopsy series. J Clin Gastroenterol 12: 460-465, 1990.
103. Nakhleh RE, Snover DC: Use of alpha-1-antitrypsin staining in the diagnosis of nodular regenerative hyperplasia of the liver. Hum Pathol 19: 1048-1052, 1988.
104. Qizilbash AH, Castelli M: Nodular regenerative hyperplasia of the liver: diagnosis by liver biopsy. Canad Med Assoc J 122: 1151-1154, 1980.
105. Reynolds WJ, Wanless IR: Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: A morphometric study suggesting a role for hepatic arteritis in the pathogenesis. J Rheumatol 11: 838-842, 1984.
106. Sherlock S, Feldman CA, Moran B, Scheuer PJ: Partial nodular transformation of the liver with portal hypertension. Am J Med 40: 195-203, 1966.
107. Snover DC, Weisdorf S, Bloomer J, et al: Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 9: 443-448, 1989.
108. Sogaard PE: Nodular transformation of the liver, alpha-fetoprotein, and hepatocellular carcinoma. Hum Pathol 12: 1052-1054, 1981.
109. Solis-Herruzo JA, Vidal JV, Colina F, et al: Nodular regenerative hyperplasia of the liver associated with the toxic oil syndrome. Report of five cases. Hepatology 6: 687-693, 1986.
110. Stromeyer FW, Ishak KG: Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 12: 60-71, 1981.
111. Thung SN, Gerber MA, Bodenheimer HC Jr: Nodular regenerative hyperplasia of the liver in a patients with diabetes mellitus. Cancer 49: 543-546, 1982.
112. Wanless IR: Micronodular transformation (nodular regenerative hyperplasia of the liver: A report of 64 cases among 2,500 autopsies and a new classificaion of benign hepatocellular nodules. Hepatology 11: 787-797, 1990.
113. Wanless IR, Godwin TA, Allen F, Feder A: Nodular regenerative hyperplasia of the liver in hematologic disorders: A possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine 59: 367-379, 1980.
114. Wanless IR, Lentz JS, Roberts ES: Partial nodular transformation of the liver in an adult with persistent ductus venosus. Review with hypothesis on pathogenesis. Arch Pathol Lab Med 109: 427-432, 1985.
115. Weinbren K, Mutum SS: Pathological aspects of diffuse nodular hyperplasia of the liver. J Pathol 143: 81-92, 1984.
116. Yutani C, Imakita M, Ishibashi-Ueda H, et al: Nodular regenerative hyperplasia of the liver associated with primary pulmonary hypertension. Hum Pathol 19: 726-731, 1988.